Evidence map›Paper›PMID 32903633›Full record

ArticleFrontiers in medicine2020

Microcirculation vs. Mitochondria-What to Target?

Tamara Merz, Nicole Denoix, Markus Huber-Lang, Mervyn Singer, Peter Radermacher, Oscar McCook

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Microcirculation and Mitochondria: The Critical Unit.Journal of clinical medicine · 2023
    Review
  6. Review
  7. Local Mucosal COFrontiers in medicine · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tamara MerzInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Ulm, Germany.
Nicole DenoixClinic for Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
Markus Huber-LangInstitute for Clinical and Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, Germany.
Mervyn SingerBloomsbury Institute for Intensive Care Medicine, University College London, London, United Kingdom.
Peter RadermacherInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Ulm, Germany.
Oscar McCookInstitute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Ulm, Germany.
Universität Ulm · DEUniversity College London · GBUniversity Hospital Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulatory shock is associated with marked disturbances of the macro- and microcirculation and flow heterogeneities. Furthermore, a lack of tissue adenosine trisphosphate (ATP) and mitochondrial dysfunction are directly associated with organ failure and poor patient outcome. While it remains unclear if microcirculation-targeted resuscitation strategies can even abolish shock-induced flow heterogeneity, mitochondrial dysfunction and subsequently diminished ATP production could still lead to organ dysfunction and failure even if microcirculatory function is restored or maintained. Preserved mitochondrial function is clearly associated with better patient outcome. This review elucidates the role of the microcirculation and mitochondria during circulatory shock and patient management and will give a viewpoint on the advantages and disadvantages of tailoring resuscitation to microvascular or mitochondrial targets.

Indexed as

circulatory shockhypoxiainflammationorgan failureoxidative stress

Identifiers

PMID32903633
PMCPMC7438707
OpenAlexW3046932381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.